热搜第一！股价大跌 霸王茶姬回应“咖啡因”

Core Viewpoint - The company BaWang Tea Ji has faced significant stock price decline due to caffeine-related controversies, leading to discussions on social media and a drop to an all-time low since its IPO [2][3][6]. Group 1: Stock Performance - On December 27, BaWang Tea Ji's stock price fell sharply, reaching a new low since its listing, with a drop of over 64% compared to its initial public offering in April [6]. - The stock experienced a pre-market decline of 10% and opened with a nearly 16% drop, closing at $11.9 per share [6]. Group 2: Caffeine Controversy - The controversy began when a self-media commentator suggested that high-caffeine beverages like those from BaWang Tea Ji are "skirting the edge of being a drug" [3]. - Many consumers reported adverse effects after consuming the drinks, such as insomnia and palpitations, which fueled the online discussions [3]. Group 3: Company Response - In response to the controversy, BaWang Tea Ji acknowledged the concerns regarding caffeine content and stated that they would take legal action against false information [4]. - The company clarified that their tea drinks have caffeine levels comparable to a latte and significantly lower than that of an Americano, emphasizing their commitment to using whole leaf tea [8]. - BaWang Tea Ji has introduced a product called "Light Caffeine · Bo Ya Jue Xuan," which reduces caffeine content by approximately 50%, and is exploring the possibility of creating caffeine-free tea options [8].